FAM
FATE icon

Fred Alger Management’s Fate Therapeutics FATE Stock Holding History

Fred Alger Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,837
Closed -$1.35M – 493
2020
Q4 		$1.35M Sell
14,837
-13,326
-47% -$828K ﹤0.01% 351
2020
Q3 		$1.13M Sell
28,163
-5,003
-15% -$175K ﹤0.01% 335
2020
Q2 		$1.14M Buy
33,166
+5,166
+18% +$154K ﹤0.01% 341
2020
Q1 		$622K Sell
28,000
-20,000
-42% -$506K ﹤0.01% 348
2019
Q4 		$939K Buy
48,000
+8,000
+20% +$127K ﹤0.01% 348
2019
Q3 		$621K Buy
40,000
+30,000
+300% +$575K ﹤0.01% 362
2019
Q2 		$203K Buy
+10,000
New +$180K ﹤0.01% 400
2018
Q4 		– Sell
-11,000
Closed -$179K – 534
2018
Q3 		$179K Buy
+11,000
New +$130K ﹤0.01% 389

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return